A prematurely terminated phase 2, randomised trial to evaluate immunogenicity and reactogenicity of a single versus two-dose primary vaccination regimen of the mRNA vaccine BNT162b2 in previously SARS-CoV-2 infected children 5-11 years old (CoVacc trial)
Bron
Vaccine - ISSN 0264-410X-88 (2026) p.
Immunogenicity, reactogenicity, and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED)-final report
Bron
International journal of infectious diseases - ISSN 1201-9712-165 (2026) p. 1-12
Multi-antigen serology and a diagnostic algorithm for the detection of arbovirus infections as novel tools for arbovirus preparedness in southeast Europe (MERMAIDS-ARBO) a prospective observational study
Bron
The lancet infectious diseases - ISSN 1473-3099-25:6 (2025) p. 678-689
Prevalence, clinical management, and outcomes of adults hospitalised with endemic arbovirus illness in southeast Europe (MERMAIDS-ARBO) : a prospective observational study
Bron
The lancet infectious diseases - ISSN 1473-3099-25:6 (2025) p. 690-700
Impact of co-infection with SARS-CoV-2 and other respiratory viruses on illness : Pooled analyses of 11 COVID-19 cohorts
Bron
The journal of infection - ISSN 0163-4453-90:6 (2025) p. 1-8